IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Finland

  • ID: 1408480
  • Report
  • Region: Finland
  • 42 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Healthcare System
  • Funding
  • Pharmaceutical Savings Measures

2. Pricing

  • Prescription Drugs
  • Application
  • Decision
  • Generic Pricing Rules
  • Reference Price System
  • Biosimilars
  • Hospital Drugs
  • Pricing Regulations
  • Actual Prices
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Application
  • Expert Advisory Group
  • Restricted Basic Reimbursement
  • Decision
  • Exclusions
  • Restricted Special Reimbursement
  • Decision
  • Reimbursement Categories
  • Reimbursement Prices
  • Hospital Reimbursement
  • Formularies
  • Oral vs IV Prescribing
  • Funding
  • Changes in Reimbursement Status
  • Scheduled Reviews
  • Reference-priced Drugs
  • Reimbursement Categories
  • Delistings
  • Indication Extensions
  • New Presentations
  • Changes in Reimbursement Prices
  • Price Cuts
  • Price Revisions
  • Scheduled Price Reviews
  • Other Reviews
  • Reference Price System
  • New Presentations

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Guidance
  • National HTA Guidelines

5. Price Build Up

  • Wholesalers
  • Retail Pharmacies
  • Margins
  • Discounts
  • Pharmacy Tax
  • Background
  • OTCs
  • Dose Dispensing
  • E-pharmacy
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Patient Co-payments
  • Pharmaceuticals
  • Healthcare
  • Prescribing Controls
  • Prescribing Limits
  • Feedback
  • Prescribing Systems
  • Prescribing Guidelines
  • Other Prescribing Information
  • Nurse Prescribing
  • E-prescriptions
  • Generics
  • Generic Substitution
  • INN Prescribing
  • Process-patented Drugs
  • Biosimilars
  • Rx-to-OTC Switches
  • Switches
  • OTC Sales
  • Parallel Trade
  • Parallel Imports
  • Parallel Exports

7. Future Developments

  • Outlook
  • Pharmaceutical Cost Containment
  • Conditional Reimbursement
  • Healthcare & Social Welfare (SOTE) Reforms

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll